Overview
Kin-hang Kok practices in Hong Kong Special Administrative Region, China. Kok is highly rated in 1 condition, according to our data. Their top areas of expertise are Severe Acute Respiratory Syndrome (SARS), COVID-19, Zika Virus Disease, and Avian Influenza.
Their clinical research consists of co-authoring 80 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Severe Acute Respiratory Syndrome (SARS)
- Experienced
- Adult T-Cell LeukemiaKok isExperienced. Learn about Adult T-Cell Leukemia.
- Atypical PneumoniaKok isExperienced. Learn about Atypical Pneumonia.
- Avian InfluenzaKok isExperienced. Learn about Avian Influenza.
- COVID-19Kok isExperienced. Learn about COVID-19.
- FluKok isExperienced. Learn about Flu.
- Middle East Respiratory Syndrome (MERS)